Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ANZCTR |
Last refreshed on:
|
13 January 2020 |
Main ID: |
ACTRN12614001215617 |
Date of registration:
|
19/11/2014 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
How long rocuronium lasts when given subcutaneously to adult surgical patients
|
Scientific title:
|
A double-blinded randomised clinical trial comparing the time of onset, duration and clinical effects of subcutaneous vs intravenous rocuronium in adult surgical patients |
Date of first enrolment:
|
01/02/2015 |
Target sample size:
|
20 |
Recruitment status: |
Withdrawn |
URL:
|
https://anzctr.org.au/ACTRN12614001215617.aspx |
Study type:
|
Interventional |
Study design:
|
Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Pharmacokinetics / pharmacodynamics;
|
Phase:
|
Phase 4
|
|
Countries of recruitment
|
Australia
| | | | | | | |
Contacts
|
Name:
|
Dr Sam Wong
|
Address:
|
Department of Anaesthesia,
Fremantle Hospital,
Alma Street,
Fremantle,
WA, 6160
Australia |
Telephone:
|
+61 8 9431 3333 |
Email:
|
sam.wong@health.wa.gov.au |
Affiliation:
|
|
|
Name:
|
Dr Sam Wong
|
Address:
|
Department of Anaesthesia,
Fremantle Hospital,
Alma Street,
Fremantle,
WA, 6160
Australia |
Telephone:
|
+61 8 9431 3333 |
Email:
|
sam.wong@health.wa.gov.au |
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Elective or semi-elective surgery (surgery not required within 24 hours of being booked)
Age 18-64
Expected duration of anaesthesia >6 hours
Planned admission to the intensive care unit after surgery
Exclusion criteria: Emergency surgery (surgery within 24 hours of procedure being booked)
Patients unable to give informed consent
Severe renal impairment (eGFR <30ml/min)
Significant hepatic impairment (known history of cirrhosis or liver dysfunction)
History of neuromuscular disease (e.g. poliomyelitis, myasthenia gravis, eaton-lambert syndrome)
Patients taking long term medications: lithium, phenytoin, carbamazepine
Administration of other muscle relaxant in previous 24 hours (suxamethonium or other non-depolarising muscle relaxant)
Pregnant or breastfeeding women
Patients requiring muscle relaxation to facilitate surgery
Patients having surgery where muscle relaxation is contraindicated
Significant possibility of anaesthetic ending prior to 6 hours (for instance – intra-abdominal surgery that may be abandoned due to disease progression that can only be decided after starting operation)
Age minimum:
18 Years
Age maximum:
64 Years
Gender:
Both males and females
|
Health Condition(s) or Problem(s) studied
|
Inadvertent subcutaneous injection of rocuronium; Inadvertent subcutaneous injection of rocuronium
|
Anaesthesiology - Anaesthetics
|
Intervention(s)
|
0.6mg/kg subcutaneous rocuronium, single bolus dose administered following induction of anaesthesia prior to commencement of surgery
|
Primary Outcome(s)
|
Duration of muscle relaxation until train-of-four ratio recovers to 90% as measured by NMT (neuro-muscular transmission) kinemyography monitor[Every 5 minutes during surgery until muscle relaxation resolves]
|
Secondary Outcome(s)
|
Time from administration of rocuronium until the greatest degree of muscle relaxation occurs as measured by NMT (neuro-muscular transmission) kinemyography monitor[Every 20 seconds following administration of rocuronium until greatest degree of muscle relaxation occurs]
|
Time from administration of rocuronium until a train-of-four count of 1/4 returns as measured by NMT (neuro-muscular transmission) kinemyography monitor[Every 5 minutes during surgery until muscle relaxation recovers to a train-of-four count of 1/4]
|
Time from administration of rocuronium until the first twitch height recovers from 25% of baseline to 75% of baseline as measured by NMT (neuro-muscular transmission) kinemyography monitor (recovery index)[Every 5 minutes during surgery until muscle relaxation recovers from a first twitch of 25% to 75% of baseline]
|
Time from administration of rocuronium until a train-of-four count of 2/4 returns as measured by NMT (neuro-muscular transmission) kinemyography monitor[Every 5 minutes during surgery until muscle relaxation recovers to a train-of-four count of 2/4]
|
Greatest degree of muscle relaxation produced by rocuronium as measured by NMT (neuro-muscular transmission) kinemyography monitor[Every 20 seconds following administration of rocuronium until greatest degree of muscle relaxation occurs]
|
Time from administration of rocuronium until train-of-four count falls to 0/4 as measured by NMT (neuro-muscular transmission) kinemyography monitor[Every 20 seconds following administration of rocuronium until specified degree of muscle relaxation occurs]
|
Source(s) of Monetary Support
|
Department of Anaesthesia,
Fremantle Hospital
|
Ethics review
|
Status: Not approved
Approval date:
Contact:
South Metropolitan Health Service Human Research Ethics Committee
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|